Gencurix Statistics
Total Valuation
Gencurix has a market cap or net worth of KRW 40.47 billion. The enterprise value is 48.42 billion.
Market Cap | 40.47B |
Enterprise Value | 48.42B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Gencurix has 15.24 million shares outstanding. The number of shares has increased by 49.46% in one year.
Shares Outstanding | 15.24M |
Shares Change (YoY) | +49.46% |
Shares Change (QoQ) | +1.15% |
Owned by Insiders (%) | 15.28% |
Owned by Institutions (%) | 7.74% |
Float | 11.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.63 |
PB Ratio | 3.61 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.40 |
EV / Sales | 16.61 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.28 |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 125.39.
Current Ratio | 0.22 |
Quick Ratio | 0.15 |
Debt / Equity | 125.39 |
Debt / EBITDA | n/a |
Debt / FCF | -0.95 |
Interest Coverage | -17.01 |
Financial Efficiency
Return on equity (ROE) is -112.87% and return on invested capital (ROIC) is -26.91%.
Return on Equity (ROE) | -112.87% |
Return on Assets (ROA) | -23.43% |
Return on Capital (ROIC) | -26.91% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.10 |
Inventory Turnover | 1.70 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.64% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -62.64% |
50-Day Moving Average | 2,855.80 |
200-Day Moving Average | 3,877.95 |
Relative Strength Index (RSI) | 44.20 |
Average Volume (20 Days) | 1,590,358 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gencurix had revenue of KRW 2.91 billion and -14.25 billion in losses. Loss per share was -1,027.57.
Revenue | 2.91B |
Gross Profit | 1.71B |
Operating Income | -11.42B |
Pretax Income | -15.13B |
Net Income | -14.25B |
EBITDA | -10.00B |
EBIT | -11.42B |
Loss Per Share | -1,027.57 |
Balance Sheet
The company has 773.79 million in cash and 10.75 billion in debt, giving a net cash position of -9.97 billion or -654.29 per share.
Cash & Cash Equivalents | 773.79M |
Total Debt | 10.75B |
Net Cash | -9.97B |
Net Cash Per Share | -654.29 |
Equity (Book Value) | 8.57B |
Book Value Per Share | 734.60 |
Working Capital | -10.06B |
Cash Flow
In the last 12 months, operating cash flow was -9.26 billion and capital expenditures -2.05 billion, giving a free cash flow of -11.31 billion.
Operating Cash Flow | -9.26B |
Capital Expenditures | -2.05B |
Free Cash Flow | -11.31B |
FCF Per Share | -741.62 |
Margins
Gross Margin | 58.76% |
Operating Margin | -391.78% |
Pretax Margin | -519.31% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -387.92% |
Dividends & Yields
Gencurix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -49.46% |
Shareholder Yield | -49.46% |
Earnings Yield | -38.70% |
FCF Yield | -27.93% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |